Lux Industries’ revenue from operations surged 22 per cent YoY to Rs 553.6 crore in Q3 FY25, compared to Rs 451.4 crore in Q3 FY24.

The company’s revenue from operations grew by 4.8 per cent YoY to Rs 1,388 crore, compared to Rs 1,325 crore in Q3 FY24.

Net profit surged 21.50 per cent YoY to Rs 110.53 crore, up from Rs 90.97 crore in the same quarter last year.

The net NPA remained steady at 1.63 per cent as of 31 December 2024, consistent with the previous quarter but slightly higher than 1.36 per cent recorded in the same quarter last year.

Prominent investor Vijay Kedia holds a 1.09 per cent stake in the company as of December 2024.

PCBL’s stock has delivered a 35.02 per cent return over the past year, significantly outperforming the Nifty 50, which rose by 5.09 per cent during the same period. Over the past three years, PCBL has rewarded investors with multibagger returns of 200 per cent.

The stock traded 7.1 per cent lower, hitting an intraday low of Rs 2,274 on the NSE.

The new extrusion line will enable the production of profiles up to 300 mm in width. Annual capacity has doubled from 12,000 MT to 24,000 MT.

Under the agreement, Akums will receive an upfront payment of EUR 100 million (Rs 880 crore) to fund product development and secure European regulatory approvals for its oral liquid manufacturing facility.

Bharat Global Developers Ltd. mentioned that the company is committed to regulatory compliance, transparency, and corporate governance.